Annals of Clinical and Translational Neurology

Article	Citations
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	107
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	102
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	73
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	66
Cognitive impairment in pulmonary arterial hypertension	64
Order from chaos: Using CSF proteomics to predict ALS progression	63
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	56
Discrepant expressive language lateralization in children and adolescents with epilepsy	54
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	51
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	50
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	50
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	48
Issue Information	47
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	46
The case of a 49‐year‐old man with involuntary toe movements	42
Association of serum Spp1 levels with disease progression in ALS and SBMA	41
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	41
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	41
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	40
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica	39
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	37
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	36
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	36
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	35
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	35

The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	33
Peripheral nervous system manifestations of MOG antibody associated disease	33
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	32
Issue Information	32
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	31
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience	31
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	31
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source	31
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy	30
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease	30
Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes	30
Visceral and emotional responses to direct electrical stimulations of the cortex	30
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	30
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)	30
The brain–heart interaction in epilepsy: implications for diagnosis, therapy, and SUDEP prevention	30
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	30
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy	29
Corrigendum: Genome sequencing in persistently unsolved white matter disorders	29
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	29
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	28
Cerebellar impulsivity–compulsivity assessment scale	28
Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway	27
Issue Information	27
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy	27
Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study	27
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis	27
Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study	27
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders	27
Cortical networks of parkinsonian gait: a metabolic and functional connectivity study	26
Epidural stimulation with locomotor training ameliorates unstable blood pressure after tetraplegia. A case report	26
Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum	25
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease	25
Horizontal gaze palsy with progressive scoliosis: Further expanding the ROBO3 spectrum	24
Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks	24
TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function	24
Issue Information	23
COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis	23
Adult‐onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS	23
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting	23
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling	23
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2‐allelic disorders	23
Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics	23
Long‐term continuation of anti‐seizure medications after acute stroke	23
Issue Information	23
Novel dominant distal titinopathy phenotype associated with copy number variation	23
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria	22
Sleep disturbance and memory dysfunction in early multiple sclerosis	22
Laser interstitial thermal therapy in the management of bottom‐of‐sulcus dysplasia‐related epilepsy	22
Issue Information	22
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis	21

CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity	21
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial	20
The case of an 85‐year‐old female with acute right hemiparesis with status epilepticus	20
	20
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis	20
Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases	20
Modifiable factors associated with Huntington's disease progression in presymptomatic participants	19
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis	19
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis	19
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome	19
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features	19
Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy	19
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis	18
Issue Information	18
Comparison of plasma and CSF biomarkers in predicting cognitive decline	18
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy	18
Gut microbiome is associated with multiple sclerosis activity in children	18
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion	18
Humoral response to neurofilaments and dipeptide repeats in ALS progression	18
Cerebello‐Prefrontal Connectivity Underlying Cognitive Dysfunction in Spinocerebellar Ataxia Type 2	18
Voxel‐based dysconnectomic brain morphometry with computed tomography in Down syndrome	17
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease	17
RETRACTION: Mechanism of ARPP21 antagonistic intron miR‐128 on neurological function repair after stroke	17
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy	17
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study	17
Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy	17
A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family	17
Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long‐term	17
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy	17
A machine learning approach to predict quality of life changes in patients with Parkinson's Disease	17
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease	16
Issue Information	16
	16
Benchmarking the proteomic profile of animal models of mesial temporal epilepsy	16
Innovative technology‐based interventions in Parkinson's disease: A systematic review and meta‐analysis	16
	16
Nanopore 16S sequencing enhances the detection of bacterial meningitis after neurosurgery	16
Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy	16
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis	16
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China	16
Non‐neurological factors associated with serum neurofilament levels in the United States population	15
Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”	15
Infliximab in neurosarcoidosis: a systematic review and meta‐analysis	15
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis	15
LRRK2 and Parkinson's disease: from genetics to targeted therapy	15
CIDP/autoimmune nodopathies with nephropathy: a case series study	15
Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy	15
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X‐associated tremor/ataxia syndrome	15
Diaphragm dysfunction in severe COVID‐19 as determined by neuromuscular ultrasound	15
Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy	15
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting	15
L1CAM variants cause two distinct imaging phenotypes on fetal MRI	15
A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants	15
Remyelination varies between and within lesions in multiple sclerosis following bexarotene	15
Power training alters somatosensory cortical activity of youth with cerebral palsy	15
Upregulation of RCAN1.4 by HIF1α alleviates OGD‐induced inflammatory response in astrocytes	14
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset	14
Argatroban plus alteplase in posterior versus anterior circulation stroke	14
Scientific rationale for a higher dose of nusinersen	14
Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia	14
After early mTICI 2b, stop or continue? Insights from the PERSIST Registry	14
	14
Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies	14
Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis	14
	14
4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders	13
Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy	13
Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care	13
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia	13
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy	13
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”	13
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's	13
Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations	13
A machine‐learning approach for predicting impaired consciousness in absence epilepsy	13
Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy	13
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia	13
“Brain age” predicts disability accumulation in multiple sclerosis	13
The Multiple Sclerosis Treatment Optimization Program	13
Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature	13
Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL	13

Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis	13
Odor identification predicts the transition of patients with isolated RBD: A retrospective study	13
Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies	13
Pupillary dynamics predict long‐term outcome in a cohort of acute traumatic brain injury coma patients	13
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	13
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	12
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers	12
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	12
A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage	12
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	12
Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia	12
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	12
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	12
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	12
Psychotropic medication use and Parkinson's disease risk amongst older women	12
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	12
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	12
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum	12
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	12
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	12
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	12
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	12
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder	11
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	11
	11
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	11
White matter microstructures in Parkinson's disease with and without impulse control behaviors	11
Psoriasis and dementia: A population‐based matched cohort study of adults in England	11
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	11
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	11
Issue Information	11
First‐ever acute ischemic strokes in HIV‐infected persons: A case–control study from stroke units	11
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population	11
Cortical signature of depressive symptoms in frontotemporal dementia: A surface‐based analysis	11
Childhood‐onset progressive dystonia associated with pathogenic truncating variants in CHD8	11
CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM	11
Using electronic health data to explore effectiveness of ICU EEG and anti‐seizure treatment	11
Lipid levels and the risk of dementia: A dose–response meta‐analysis of prospective cohort studies	11
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	11
Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease	11
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder	11
Disorder of consciousness: Structural integrity of brain networks for the clinical assessment	11
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?	11
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome	11
Efficacy of melatonin in term neonatal models of perinatal hypoxia‐ischaemia	10
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis	10
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis	10
Transcriptome analysis of collagen VI‐related muscular dystrophy muscle biopsies	10
Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials	10
Does long‐term phenytoin have a place in Dravet syndrome?	10
Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody	10
Exploring triheptanoin as treatment for short chain enoyl CoA hydratase deficiency	10
Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke	10
Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)	10
Genetic spectrum in a cohort of patients with distal hereditary motor neuropathy	10
Axonal injury, sleep disturbances, and memory following traumatic brain injury	10
Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY‐associated diseases	10
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	10
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	10
Impact of lipid profiles on parenchymal hemorrhage and early outcome after mechanical thrombectomy	10
Amyloidogenicity assessment of transthyretin gene variants	10
Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null mice	10
Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study	9
Associative cued asynchronous BCI induces cortical plasticity in stroke patients	9
No strong HLA association with MOG antibody disease in the UK population	9
Homozygous variant in COQ7 causes autosomal recessive hereditary spastic paraplegia	9
Using chronic recordings from a closed‐loop neurostimulation system to capture seizures across multiple thalamic nuclei	9
Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes	9
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia	9
Expanding the phenotypic spectrum of BCS1L‐related mitochondrial disease	9
Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis	9
Mutations in the tail and rod domains of the neurofilament heavy‐chain gene increase the risk of ALS	9
Clinical characteristics of low‐grade tumor‐related epilepsy and its predictors for surgical outcome	9
The neural correlates of topographical disorientation—a lesion analysis study	9
Issue Information	9
Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy	9
Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States	9
Swallowing‐related neural oscillation: an intracranial EEG study	9
Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification	9
Blood–brain barrier profile pretreatment is associated with hemorrhagic transformation after endovascular reperfusion	9
Music Interventions in Hyperacute and Acute Stroke Patients: A Randomized Controlled Pilot Feasibility Study	9
Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis	9
Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China	8
Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?	8
Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease	8
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy	8
Nuclear pore pathology underlying multisystem proteinopathy type 3‐related inclusion body myopathy	8
Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort	8
The localization and lateralization of fear aura and its surgical prognostic value in patients with focal epilepsy	8
Case of a 57‐year‐old woman with acute confusion and inability to recognize her husband	8
CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection‐triggered encephalopathy syndromes	8
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment	8
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study	8
Diffusion spectrum imaging predicts hippocampal sclerosis in mesial temporal lobe epilepsy patients	8
Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort	8